CLEARVIEW LIMITED Trademark
Trademark Overview
On Tuesday, July 15, 2003, a trademark application was filed for CLEARVIEW LIMITED with the United States Patent and Trademark Office. The USPTO has given the CLEARVIEW LIMITED trademark a serial number of 78274211. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 6, 2004. This trademark is owned by Clearview Limited. The CLEARVIEW LIMITED trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
IC 042; US 100 101; S-- consulting services in the field of pharmacogenomics, biotechnology, pharmaceutical, and genomics industries; providing research, advice and guidance on strategic and tactical direction for use in operational performance and operational improvement in said fields; FIRST USE-- 20030600; FIRST USE IN COMMERCE-- 20030700 IC 035; US 100 101 102; S-- business management and business management consultation all in the fields of pharmacogenomics, biotechnology, pharmaceutical, and genomics industries; competitive research, advice, market assessment, namely, consultation and research in the area of emerging scientific advancements and commercial direction associated with said industries; FIRST USE-- 20030600; FIRST USE IN COMMERCE-- 20030700
General Information
| Serial Number | 78274211 |
| Word Mark | CLEARVIEW LIMITED |
| Filing Date | Tuesday, July 15, 2003 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, September 6, 2004 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | IC 042; US 100 101; S-- consulting services in the field of pharmacogenomics, biotechnology, pharmaceutical, and genomics industries; providing research, advice and guidance on strategic and tactical direction for use in operational performance and operational improvement in said fields; FIRST USE-- 20030600; FIRST USE IN COMMERCE-- 20030700 IC 035; US 100 101 102; S-- business management and business management consultation all in the fields of pharmacogenomics, biotechnology, pharmaceutical, and genomics industries; competitive research, advice, market assessment, namely, consultation and research in the area of emerging scientific advancements and commercial direction associated with said industries; FIRST USE-- 20030600; FIRST USE IN COMMERCE-- 20030700 |
| Pseudo Mark | CLEAR VIEW LIMITED |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 4, 2003 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Clearview Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Carrboro, NC 27510 |
Trademark Events
| Event Date | Event Description |
| Thursday, October 7, 2004 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 16, 2004 | EMAIL RECEIVED |
| Monday, September 6, 2004 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, February 9, 2004 | NON-FINAL ACTION E-MAILED |
| Thursday, January 29, 2004 | ASSIGNED TO EXAMINER |
